pmc logo image
Logo of brmedjBMJ helping doctors make better decisionsSearchLatest content

Formats:

Br Med J. 1959 January 17; 1(5115): 172, 173.
PMCID: PMC1992229
Hazards of Meprobamate
B. W. Cromie
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (467K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • HAIZLIP TM, EWING JA. Meprobamate habituation: a controlled clinical study. N Engl J Med. 1958 Jun 12;258(24):1181–1186. [PubMed]
  • STOUGH AR. Possible habituating properties of meprobamate; clinical study in an institutionalized, highly susceptible population. J Am Med Assoc. 1958 Feb 22;166(8):882–888. [PubMed]
  • BOYD LJ, CAMMER L, MULINOS MG, HUPPERT VF, HAMMER H. Meprobamate addiction. J Am Med Assoc. 1958 Dec 6;168(14):1839–1843. [PubMed]
  • WOODWARD MG. Attempted suicide with meprobamate. Northwest Med. 1957 Mar;56(3):321–322. [PubMed]
  • SELLING LS. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate). J Am Med Assoc. 1955 Apr 30;157(18):1594–1596. [PubMed]
  • HIESTAND EC. Overdosage with meprobamate; presentation of case. Ohio Med. 1956 Dec;52(12):1306–1307. [PubMed]
  • ALLEN AG, BLACK AV. Near-fatal case of intoxication with meprobamate treated with electro-stimulation and levarterenol. Ohio Med. 1956 Dec;52(12):1303. [PubMed]
  • POWELL LW, Jr, MANN GT, KAYE S. Acute meprobamate poisoning. N Engl J Med. 1958 Oct 9;259(15):716–718. [PubMed]
  • MEYER LM, HEEVE WL, BERTSCHER RW. Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy. N Engl J Med. 1957 Jun 27;256(26):1232–1233. [PubMed]
  • SARGANT W. Sedatives and tranquillizers. II. Br Med J. 1958 Nov 1;2(5103):1095–1096. [PubMed]